Current update on cellular and molecular mechanisms of hereditary angioedema

Annals of Allergy, Asthma and Immunology

Volumn 112, Issue 5, 2014, Pages 413-418

  Walford, Hannah H ^a   Zuraw, Bruce L ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; BRADYKININ; COMPLEMENT COMPONENT C1S INHIBITOR; ESTROGEN; HORMONE; SERINE PROTEINASE INHIBITOR;

ANGIONEUROTIC EDEMA; BLOOD VESSEL PERMEABILITY; C1 ESTERASE INHIBITOR DEFICIENCY; COMPLEMENT SYSTEM; DISEASE CLASSIFICATION; DISEASE SEVERITY; DNA POLYMORPHISM; FXII GENE; GENE; GENE MUTATION; GENETIC DISORDER; HEREDITARY ANGIOEDEMA WITH C1 ESTERASE INHIBITOR DEFICIENCY; HEREDITARY ANGIOEDEMA WITH NORMAL C1 ESTERASE INHIBITOR LEVEL; HORMONE ACTION; HUMAN; INFECTION; INJURY; MOLECULAR PATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; REVIEW; SERPING 1 GENE; STRESS;

ANGIOEDEMAS, HEREDITARY; BRADYKININ; CHILD; COMPLEMENT C1 INACTIVATOR PROTEINS; ESTROGENS; FACTOR XII; FACTOR XII DEFICIENCY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE;

EID: 84899514103     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.12.023     Document Type: Review

References (55)

1. H.I. Quincke Ü ber akutes umschriebenes Hautödem [About an acute described skin edema] Monatshe Prakt Dermatol 1 1882 129 131
2. W. Osler Hereditary angio-neurotic oedema The American Journal of the Medical Sciences 95 1888 362 367
3. V.H. Donaldson, and R.R. Evans A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C′1- esterase Am J Med 35 1963 37 44
4. B.L. Zuraw Clinical practice. Hereditary angioedema N Engl J Med 359 2008 1027 1036
5. M. Cicardi, K. Bork, and T. Caballero et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group Allergy 67 2012 147 157
6. B.L. Zuraw, K. Bork, and K.E. Binkley et al. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel Allergy Asthma Proc 33 suppl 1 2012 S145 S156
7. B.L. Zuraw, J.A. Bernstein, and D.M. Lang et al. A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema J Allergy Clin Immunol 131 2013 1491 1493.e25
8. T. Craig, E.A. Pursun, and K. Bork et al. WAO guideline for the management of hereditary angioedema World Allergy Organ J 5 2012 182 199
9. D.M. Lang, W. Aberer, and J.A. Bernstein et al. International consensus on hereditary and acquired angioedema Ann Allergy Asthma Immunol 109 2012 395 402
10. K.E. Binkley, and A. Davis III Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema J Allergy Clin Immunol 106 2000 546 550
11. K. Bork, S.E. Barnstedt, P. Koch, and H. Traupe Hereditary angioedema with normal C1-inhibitor activity in women Lancet 356 2000 213 217
12. K. Bork Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor Allergy Asthma Clin Immunol 6 2010 15
13. M.M. Frank, J.A. Gelfand, and J.P. Atkinson Hereditary angioedema: the clinical syndrome and its management Ann Intern Med 84 1976 586 593
14. K. Bork, J. Hardt, and G. Witzke Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency J Allergy Clin Immunol 130 2012 692 697
15. H. Longhurst, and M. Cicardi Hereditary angio-oedema Lancet 379 2012 474 481
16. B.L. Zuraw, S. Sugimoto, and J.G. Curd The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency J Allergy Clin Immunol 78 1986 1115 1120
17. L.C. Zingale, R. Castelli, A. Zanichelli, and M. Cicardi Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management Immunol Allergy Clin North Am 26 2006 669 690
18. M.M. Frank Hereditary angioedema: the clinical syndrome and its management in the United States Immunol Allergy Clin North Am 26 2006 653 668
19. S.M. Yoo, and D.A. Khan Implantable venous access device associated complications in patients with hereditary angioedema J Allergy Clin Immunol 1 2013 524 525
20. A.E. Davis III, F. Lu, and P. Mejia C1 inhibitor, a multi-functional serine protease inhibitor Thromb Haemost 104 2010 886 893
21. D.A. Lomas, D. Belorgey, and M. Mallya et al. Molecular mousetraps and the serpinopathies Biochem Soc Trans 33 2005 321 330
22. B.L. Zuraw, and J.G. Curd Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients J Clin Invest 78 1986 567 575
23. P.J. Lachmann, and F.S. Rosen The catabolism of C1-inhibitor and the pathogenesis of hereditary angio-edema Acta Pathol Microbiol Scand 92 1984 35 39
24. M. Quastel, R. Harrison, M. Cicardi, C.A. Alper, and F.S. Rosen Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema J Clin Invest 71 1983 1041 1046
25. J. Kramer, F.S. Rosen, H.R. Colten, K. Rajczy, and R.C. Strunk Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema J Clin Invest 91 1993 1258 1262
26. E. Pappalardo, M. Cicardi, and C. Duponchel et al. Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema J Allergy Clin Immunol 106 2000 1147 1154
27. E. Pappalardo, S. Caccia, C. Suffritti, A. Tordai, L.C. Zingale, and M. Cicardi Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates Mol Immunol 45 2008 3536 3544
28. A. Blanch, O. Roche, I. Urrutia, P. Gamboa, G. Fontan, and M. Lopez-Trascasa First case of homozygous C1 inhibitor deficiency J Allergy Clin Immunol 118 2006 1330 1335
29. A. Lopez-Lera, B. Favier, R.M. de la Cruz, S. Garrido, C. Drouet, and M. Lopez-Trascasa A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation J Allergy Clin Immunol 126 2010 1307 1310.e3
30. B.L. Zuraw, and J. Herschbach Detection of C1 inhibitor mutations in patients with hereditary angioedema J Allergy Clin Immunol 105 2000 541 546
31. E. Verpy, E. Couture-Tosi, E. Eldering, M. Lopez-Trascasa, and P. Spath Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function J Clin Invest 95 1995 350 359
32. G. Dewald, and K. Bork Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor Biochem Biophys Res Commun 343 2006 1286 1289
33. A.E. Davis III Mechanism of angioedema in first complement component inhibitor deficiency Immunol Allergy Clin North Am 26 2006 633 651
34. J. Dobo, B. Major, and K.A. Kekesi et al. Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1 PLoS One 6 2011 e20036
35. A.P. Kaplan Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy J Allergy Clin Immunol 126 2010 918 925
36. A.P. Kaplan, and K. Joseph The bradykinin-forming cascade and its role in hereditary angioedema Ann Allergy Asthma Immunol 104 2010 193 204
37. K. Joseph, B.G. Tholanikunnel, A. Bygum, B. Ghebrehiwet, and A.P. Kaplan Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II J Allergy Clin Immunol 132 2013 470 475
38. L.M. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D.J. Pettibone, and B.L. Zuraw International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences Pharmacol Rev 57 2005 27 77
39. F. Bossi, F. Fischetti, and D. Regoli et al. Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency J Allergy Clin Immunol 124 2009 1303 1310.e4
40. L. Bouillet, T. Mannic, and M. Arboleas et al. Hereditary angioedema: key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation J Allergy Clin Immunol 128 2011 232 234
41. K. Bork, K. Wulff, P. Meinke, N. Wagner, J. Hardt, and G. Witzke A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor Clin Immunol 141 2011 31 35
42. F. Citarella, S. Misiti, A. Felici, A. Farsetti, A. Pontecorvi, and A. Fantoni Estrogen induction and contact phase activation of human factor XII Steroids 61 1996 270 276
43. C.C. Lung, E.K.L. Chan, and B.L. Zuraw Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and C1 inhibitor deficient patients J Allergy Clin Immunol 99 1997 134 146
44. T. Freiberger, M. Vyskocilova, and L. Kolarova et al. Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema Hum Immunol 63 2002 492 494
45. D. Brull, S. Dhamrait, and S. Myerson et al. Bradykinin B2BKR receptor polymorphism and left-ventricular growth response Lancet 358 2001 1155 1156
46. G.P. Van Guilder, M. Pretorius, and J.M. Luther et al. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition Hypertension 51 2008 454 459
47. A.L. Cilia La Corte, A.M. Carter, and G.I. Rice et al. A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema Hum Mutat 32 2011 1326 1331
48. C. Drouet, A. Desormeaux, and J. Robillard et al. Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P J Allergy Clin Immunol 121 2008 429 433
49. Q.L. Duan, K. Binkley, and G.A. Rouleau Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema J Allergy Clin Immunol 123 2009 906 910
50. S.J. Campbell, I.J. Mackie, G.E. Robinson, and S.J. Machin Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill Br J Obstet Gynaecol 100 1993 79 84
51. A. Farsetti, S. Misiti, and F. Citarella et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression Endocrinology 136 1995 5076 5083
52. C. Murone, S.Y. Chai, W. Muller-Esterl, F.A. Mendelsohn, and J. Clements Localization of bradykinin B2 receptors in the endometrium and myometrium of rat uterus and the effects of estrogen and progesterone Endocrinology 140 1999 3372 3382
53. P. Madeddu, C. Emanueli, and Q. Song et al. Regulation of bradykinin B2-receptor expression by oestrogen Br J Pharmacol 121 1997 1763 1769
54. J. Gimenez, M.P. Garcia, and M. Serna et al. 17Beta-oestradiol enhances the acute hypotensive effect of captopril in female ovariectomized spontaneously hypertensive rats Exp Physiol 91 2006 715 722
55. K. Bork Hereditary angioedema with normal c1 inhibitor Immunol Allergy Clin North Am 33 2013 457 470